Please see Indication and Important Safety Information on the website.
More than 9 out of 10 commercial and Medicare Part D patients are covered for RYBELSUS® (semaglutide) tablets 7 mg or 14 mga
RYBELSUS® is widely available and already coveredb by the top 5 biggest payers.c
aData from MMIT Formulary bridge. January 2023 Nomenclature, and Xponent PlanTrack using week ending 1/20/2023.
bCoverage status and tier vary by plan. Please check directly with the health plan to confirm coverage for individual patients.
cPlan data based on number of pharmacy lives as reported by Managed Markets Insight & Technology, LLC (current as of March 2023). Applies to commercial business only. Formulary status is subject to change. Because formularies do change, and many health plans offer more than one formulary, please check directly with the health plan to confirm coverage for individual patients. 2023 Managed Markets Insight & Technology, LLC. All rights reserved.